Abstract
Candida auris is a multidrug-resistant fungal pathogen that is associated with nosocomial outbreaks in patients with extensive healthcare exposure and treatment outside the UnitedStates. The Ohio Department of Health recommends Cauris screening in high-risk patients. However, this can be operationally difficult for many healthcare facilities. This report describes a Cauris and carbapenem-resistant Enterobacterales inpatient screening program done in collaboration with state public health.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
